Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

IL-27 alleviates the bleomycin-induced pulmonary fibrosis by regulating the Th17 cell differentiation

Open access
Dong, Zhaoxing, Lu, Xin, Yang, Yanni, Zhang, Tao, Li, Yongxia, Chai, Yanlin, Lei, Wen, Li, Changbo, Ai, Li, Tai, Wenlin · 2015 · BMC Pulmonary Medicine

Abstract

BACKGROUND: Interleukin-27 (IL-27) is a multifunctional cytokine with both pro-inflammatory and immunoregulatory functions. At present, the role of IL-27 in pulmonary fibrosis remains unknown. METHODS: In this study, we observed the expression of IL-27/IL-27R in a mouse model of bleomycin (BLM)-induced pulmonary fibrosis. We verified the role of IL-27 using hematoxylin and eosin as well as Masson's staining methods and measuring the content of hydroxyproline as well as collagen I and III. We assessed the differentiation of T lymphocytes in the spleen and measured the concentration of cytokines in bronchoalveolar lavage fluid (BALF) and the expression level of relevant proteins in the JAK/STAT and TGF-ß/Smad signaling pathways in lung tissue. RESULTS: Increased IL-27 expression in BLM-induced pulmonary fibrosis was noted. IL-27 treatment may alleviate pulmonary fibrosis and increase the survival of mice. IL-27 inhibited the development of CD4(+) IL-17(+), CD4(+) IL-4(+) T, and CD4(+) Foxp3(+) cells and the secretion of IL-17, IL-4, IL-6, and TGF-ß. IL-27 induced the production of CD4(+) IL-10(+) and CD4(+) INF-γ(+) T cells. IL-27 decreased the levels of phosphorylated STAT1, STAT3, STAT5, Smad1, and Smad3 but increased the level of SOCS3. CONCLUSIONS: This study demonstrates that IL-27 potentially attenuates BLM-induced pulmonary fibrosis by regulating Th17 differentiation and cytokine secretion.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12890-015-0012-4

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 IL-27/IL-27R expression increases in bleomycin-induced pulmonary fibrosis. A. Real-time PCR for IL-27 and IL-27R, at days 3, 7, 14, and 28 in the BLM and control groups. The expression of the CT values for real-time PCR were normalized by 2-∆∆ct. B. IL-27 and IL-27R mRNA expression in the different groups. C, D. Western blot analysis; band intensities were measured using Image J. For each group, n = 3. Data are expressed as the mean ± SEM. *p < 0.05, **p < 0.01.
Figure 1 IL-27/IL-27R expression increases in bleomycin-induced pulmonary fibrosis. A. Real-time PCR for IL-27 and IL-27R, at days 3, 7, 14, and 28 in the BLM and control groups. The expression of the CT values for real-time PCR were normalized by 2-∆∆ct. B. IL-27 and IL-27R mRNA expression in the different groups. C, D. Western blot analysis; band intensities were measured using Image J. For each group, n = 3. Data are expressed as the mean ± SEM. *p < 0.05, **p < 0.01.CC BY · PubMed Central
Figure 2 Exogenous IL-27 treatment can suppress BLM-induced pulmonary fibrosis. A. Hematoxylin and eosin (HE) staining (100x) and Masson’s trichrome staining (100x) depicting the effects of exogenous IL-27 application on lung histological changes at days 7 and 28 in various treated mice. B. The alveolitis and fibrosis scores for the lungs of mice in the different groups at days 7 and 28. Values are means ± SEM (n = 5). C, D, E. Real-time PCR and Western blot analysis for COL1 and COL3, respectively, in the different groups. CT values for the real-time PCR were normalized by 2-∆∆ct. Western band intensities were measured using Image J software. For each group, n = 3. F. The lung hydroxyproline content at days 7 and 28 for mice in the various treatment groups. Hydroxyproline content was measured using an ELISA, n = 5. G. Survival rate of mice with BLM-induced pulmonary fibrosis. The percentage of survival over time is presented, n = 5. Data are expressed as means ± SEM. *p < 0.05, **p < 0.01. A: control, B: BLM group, C: BLM + IL-27 group, D: BLM + IL-27 antibody group.
Figure 2 Exogenous IL-27 treatment can suppress BLM-induced pulmonary fibrosis. A. Hematoxylin and eosin (HE) staining (100x) and Masson’s trichrome staining (100x) depicting the effects of exogenous IL-27 application on lung histological changes at days 7 and 28 in various treated mice. B. The alveolitis and fibrosis scores for the lungs of mice in the different groups at days 7 and 28. Values are means ± SEM (n = 5). C, D, E. Real-time PCR and Western blot analysis for COL1 and COL3, respectively, in the different groups. CT values for the real-time PCR were normalized by 2-∆∆ct. Western band intensities were measured using Image J software. For each group, n = 3. F. The lung hydroxyproline content at days 7 and 28 for mice in the various treatment groups. Hydroxyproline content was measured using an ELISA, n = 5. G. Survival rate of mice with BLM-induced pulmonary fibrosis. The percentage of survival over time is presented, n = 5. Data are expressed as means ± SEM. *p < 0.05, **p < 0.01. A: control, B: BLM group, C: BLM + IL-27 group, D: BLM + IL-27 antibody group.CC BY · PubMed Central
Figure 3 The effect of IL-27 treatment on T lymphocyte differentiation in the spleen after 28 days. A. Representative figures from flow cytometry analyses; CD4+ IL-4+, CD4+ IL-10+, CD4+ IL-17+, CD4+ Foxp3+ and CD4+ IFN-γ+ cells from the spleen were analyzed on day 28. B. Analyzed data. Values are expressed as means ± SEM (n = 3). *p < 0.05, **p < 0.01.
Figure 3 The effect of IL-27 treatment on T lymphocyte differentiation in the spleen after 28 days. A. Representative figures from flow cytometry analyses; CD4+ IL-4+, CD4+ IL-10+, CD4+ IL-17+, CD4+ Foxp3+ and CD4+ IFN-γ+ cells from the spleen were analyzed on day 28. B. Analyzed data. Values are expressed as means ± SEM (n = 3). *p < 0.05, **p < 0.01.CC BY · PubMed Central
Figure 4 The concentration of cytokines in the BALF of the different groups on days 7 and 28. The concentration (in pg/ml) of (A) IL-4; (B) IL-6; (C) IL-10 ; (D) TGF-β; (E) IFN-γ; and (F) IL-17. Data are expressed as means ± SEM (n = 3). *p < 0.05, **p < 0.01.
Figure 4 The concentration of cytokines in the BALF of the different groups on days 7 and 28. The concentration (in pg/ml) of (A) IL-4; (B) IL-6; (C) IL-10 ; (D) TGF-β; (E) IFN-γ; and (F) IL-17. Data are expressed as means ± SEM (n = 3). *p < 0.05, **p < 0.01.CC BY · PubMed Central
Figure 5 The expression of JAK/STAT and TGF-β/Smad signaling pathway-related proteins in the lung tissues of the different groups on days 7 and 28. A. Western blots of JAK/STAT signaling pathway-related proteins: JAK, STAT1, STAT3, STAT5, SOCS3, and phosphorylated STAT1, STAT3, and STAT5. B. A histogram of the relative gray values shown in A. C. Western blots for the TGF-β/Smad signaling pathway-related proteins: Smad1, Smad3, TGF-βR1 and phosphorylated Smad1 and Smad3. D. A histogram of the relative gray values shown in C. Data are expressed as means ± SEM (n = 3). *p < 0.05, **p < 0.01.
Figure 5 The expression of JAK/STAT and TGF-β/Smad signaling pathway-related proteins in the lung tissues of the different groups on days 7 and 28. A. Western blots of JAK/STAT signaling pathway-related proteins: JAK, STAT1, STAT3, STAT5, SOCS3, and phosphorylated STAT1, STAT3, and STAT5. B. A histogram of the relative gray values shown in A. C. Western blots for the TGF-β/Smad signaling pathway-related proteins: Smad1, Smad3, TGF-βR1 and phosphorylated Smad1 and Smad3. D. A histogram of the relative gray values shown in C. Data are expressed as means ± SEM (n = 3). *p < 0.05, **p < 0.01.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 43

Metadata

Authors
Dong, Z., Lu, X., Yang, Y., Zhang, T., Li, Y., Chai, Y., Lei, W., Li, C., Ai, L., & Tai, W.
Affiliations
Kunming Medical University (CN)
Corresponding author
Tai, Wenlin
Venue
BMC Pulmonary Medicine
Published
2015-02-18
Volume
15
Issue
1
Pages
13-13
ISSN
1471-2466 (ISSN-L)
OpenAlex
W2092666561
Cited by
42
References
31
Citations by year
2026: 1 · 2025: 8 · 2024: 2 · 2023: 6 · 2022: 3 · 2021: 5 · 2020: 3 · 2019: 3 · 2018: 2 · 2017: 3 · 2016: 5 · 2015: 1
FWCI
2.90
Type
journal article
Language
en
Open access
Locations
  • BMC Pulmonary Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Natural Science Foundation of China (81360015)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
  • Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
Keywords
IL-27, pulmonary fibrosis, bleomycin-induced lung injury, Th17 cell differentiation, IL-27 receptor, JAK/STAT signaling, TGF-β/Smad signaling, SOCS3, IL-17, IL-10, interferon-gamma, IL-4
MeSH terms
Suppressor of Cytokine Signaling 3 Protein, Animals, Antibiotics, Antineoplastic, Bleomycin, Bronchoalveolar Lavage Fluid, Cell Differentiation, Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Interleukins, Lung, Male, Mice, Inbred C57BL, Pulmonary Fibrosis, Spleen, T-Lymphocytes, Blotting, Western, Signal Transduction, Cytokines, Transforming Growth Factor beta, Receptors, Cytokine, Receptors, Interleukin, Reverse Transcriptase Polymerase Chain Reaction, STAT Transcription Factors, Suppressor of Cytokine Signaling Proteins, Mice, Smad Proteins, Janus Kinases, Th17 Cells, Real-Time Polymerase Chain Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: IL-27 alleviates the bleomycin-induced pulmonary fibrosis by regulating the Th17 cell differentiation. https://app.cochat.ai/papers/10.1186/s12890-015-0012-4
The paper
Dong, Z., Lu, X., Yang, Y., Zhang, T., Li, Y., Chai, Y., Lei, W., Li, C., Ai, L., & Tai, W. (2015). IL-27 alleviates the bleomycin-induced pulmonary fibrosis by regulating the Th17 cell differentiation. BMC Pulmonary Medicine. https://doi.org/10.1186/s12890-015-0012-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.